Search
Feed aggregator
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm 5/23/2024
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program 5/23/2024
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts 5/23/2024
BioSpace x DIA: Navigating the Emergence of CGT Combination Products
BioSpace x DIA: Navigating the Emergence of CGT Combination Products 5/23/2024
Do You Need to Love Your Job to Be Happy at Your Job?
Do You Need to Love Your Job to Be Happy at Your Job? 5/23/2024
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030 5/21/2024
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea 5/21/2024
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology 5/21/2024
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms 5/21/2024
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials 5/21/2024
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate 5/21/2024
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act 5/21/2024
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer 5/17/2024
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B 5/17/2024
Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts
Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts 5/17/2024
Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul
Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul 5/17/2024
EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA
EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA 5/17/2024
Bayer Touts Phase III Results for Menopause Symptom Drug
Bayer Touts Phase III Results for Menopause Symptom Drug 5/17/2024
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines 5/17/2024
J&J Buys Proteologix for $850M, Bispecific Antibodies for Atopic Dermatitis
J&J Buys Proteologix for $850M, Bispecific Antibodies for Atopic Dermatitis 5/16/2024
World Pharma News
- How the cheese-noodle principle could help counter Alzheimer's
- New 'sensor' lets researchers watch DNA repair in real time
- The immune system creates its own targets within viruses
- Targeted drug could benefit young patients with invasive sarcoma
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders